Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
BuchGebunden
436 Seiten
Englisch
Springererscheint am24.12.20242. Aufl.
This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment.

Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
mehr

Produkt

KlappentextThis extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment.

Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
Details
ISBN/GTIN978-3-031-74045-9
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2024
Erscheinungsdatum24.12.2024
Auflage2. Aufl.
Seiten436 Seiten
SpracheEnglisch
IllustrationenApprox. 435 p.
Artikel-Nr.17514770
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.mehr

Autor

A Martinez Rubio, is Chief of the Cardiology Department at the University Hospital of Sabadell and professor of Medicine at the Universitat Autònoma of Barcelona, Spain. Ex-president of the International Society of Cardiovascular Pharmacotherapy


J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain



G.-Andrei Dan is Distinguished/Emeritus Professor of Cardiology & Internal Medicine at the Carol Davila University of Medicine, Honorary Member of the Romanian Academy of Scientists and past President of ISCP. Profesor Dan' main expertise is electrophysiology, pharmacology of antiarrhythmic drugs, atrial fibrillation and heart failure. He wrote more than 170 scientific papers, presented more than 50 international conferences and contributed to 15 European guidelines. He is a member of the board of several prestigious medical journals, Deputy Editor of the American Journal of Therapeutics and Editor in Chief of the Romanian Journal of Internal Medicine. He is also an Honorary Citizen of the Romanian capital, Bucharest
Weitere Artikel von
Herausgegeben:Martínez-Rubio, Antoni
Weitere Artikel von
Tamargo, Juan